Clinical Testing of a D1 Agonist for Cognitive Enhancement in Schizotypal Personality Disorder
Phase 2
- Conditions
- Cognitive ImpairmentsSchizotypal Personality Disorder
- Interventions
- Drug: Placebo
- First Posted Date
- 2011-11-06
- Last Posted Date
- 2012-07-20
- Lead Sponsor
- Larry J. Siever
- Target Recruit Count
- 20
- Registration Number
- NCT01466205
- Locations
- 🇺🇸
Mount Sinai School of Medicine, New York, New York, United States
© Copyright 2025. All Rights Reserved by MedPath